Doxepin is used to treat depression, anxiety disorders, itchiness, trouble sleeping, and as a second-line treatment of chronic idiopathic urticaria (hives). Its oral formulations are FDA-approved for the treatment of depression, anxiety, and insomnia and its topical formulations are FDA-approved the short-term management (up to 8 days) of atopic dermatitis and lichen simplex chronicus.
Specification:
Items Tested |
Specification |
Result |
Characters |
White crystalline powder |
Confirms |
Assay (HPLC) |
99.0~101.0% |
99.5% |
Flash Point |
121.3°C |
Confirms |
PH |
4.5~6.5 |
Confirms |
Loss on drying |
Not more than 1.0% |
Confirms |
Residue on Ignition |
Not more than 0.1% |
Confirms |
Melting Point |
185~191°C |
Confirms |
Boiling Point |
413.3°C at 760mmHg |
Confirms |
Heavy Metal |
Not more than 20ppm |
Confirms |
Vapour Pressure |
4.87E-07mmHg at 25°C |
Confirms |
Conclusion |
Conforms USP32 |
Packaging details:
Packaging details: |
25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
Storage: |
Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
Shelf Life: |
5 years if sealed and store away from direct sun light. |